A groundbreaking study has uncovered that fetuses are likely exposed to significantly higher concentrations of per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals,” than previously realised. This revelation stems from an extensive analysis of umbilical cord blood, which revealed a staggering number of PFAS compounds present, posing serious implications for fetal health and development.
Expanded Research Unveils New Findings
Traditionally, tests of umbilical cord blood have focused on a limited selection of PFAS compounds, primarily perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, a recent study conducted by researchers at Mount Sinai examined 120 umbilical cord blood samples and employed a more comprehensive “non-targeted analysis.” This method identified 42 distinct PFAS compounds, highlighting a much broader exposure than the limited scope of previous studies suggested.
Shelley Liu, an associate professor at the Icahn School of Medicine at Mount Sinai and a co-author of the study, emphasized the critical nature of these findings: “Babies are exposed to many more PFAS than we previously thought. It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.”
Understanding PFAS and Their Risks
PFAS encompasses a vast class of over 15,000 synthetic chemicals, renowned for their water, stain, and grease-resistant properties. While they have revolutionised various industries, these substances have also been linked to an array of severe health issues, including cancer, birth defects, compromised immunity, elevated cholesterol levels, and kidney disease. Dubbed “forever chemicals,” these compounds do not naturally decompose in the environment, thus accumulating in both human bodies and the ecosystem.
A review of 40 studies on umbilical cord blood revealed that PFAS were detected in every one of the 30,000 samples analysed. Higher levels of PFAS in mothers correlate with increased infant mortality rates and can lead to complications such as low birth weight and obesity later in life. Additionally, fetal exposure to these chemicals has been associated with long-term health issues, including cancer, neurological disorders, and cardiovascular diseases.
Regulatory Lag and the Need for Action
The study shines a light on the inadequacies in current regulatory practices. The US Environmental Protection Agency (EPA) has been slow to adapt its testing methods to account for the multitude of PFAS compounds emerging in the environment. For instance, the agency typically tests water for only 30-40 PFAS compounds, while independent researchers have identified thousands. A recent analysis by The Guardian highlighted that regulatory bodies frequently underestimate PFAS contamination levels in water supplies.
The Mount Sinai research compared traditional testing methods with their expanded non-targeted analysis, revealing that the latter consistently detected more PFAS compounds. While the EPA has recently certified a blood test capable of identifying 53 PFAS compounds, Liu pointed out that their analysis uncovered 31 compounds not included in the EPA’s list, underscoring the urgency for more comprehensive testing protocols.
Implications for Future Research
Although the Mount Sinai study did not directly investigate the health implications of elevated PFAS levels in fetal blood, it raises pressing questions about the potential long-term effects on newborns. Liu noted that while the specific impacts remain unclear, higher concentrations of PFAS are generally associated with increased health risks. The blood samples analysed were part of the federal government’s Home study, which monitors individuals’ PFAS exposure and related health outcomes over time. Researchers at Mount Sinai plan to delve deeper into the health ramifications of these findings.
David Andrews, acting chief science officer at the Environmental Working Group, a non-profit organisation, remarked on the significance of the study, stating, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.”
Why it Matters
The findings of this study underscore a critical public health issue: the pervasive presence of harmful chemicals in the bodies of the most vulnerable among us. As the evidence mounts regarding the dangers posed by PFAS, it becomes increasingly imperative for regulators to adopt more stringent measures to protect against these contaminants. The health of future generations hangs in the balance, and immediate action is needed to mitigate this growing crisis. The time for robust health-protective policies is now; our babies deserve a cleaner, safer start to life.
